First Page | Document Content | |
---|---|---|
Oncology Melanoma Organochlorides Vemurafenib Dacarbazine Ipilimumab BRAF Protein kinase inhibitor End point of clinical trials Chemistry Medicine Organofluorides | dabrafenib, 50mg and 75mg hard capsules (Tafinlar®) GlaxoSmithKline SMC No. (No[removed]February 2015Add to Reading ListSource URL: www.scottishmedicines.org.ukDownload Document from Source WebsiteFile Size: 460,72 KBShare Document on Facebook |
CURRENT ENVIRONMENTAL SOLUTIONSDocID: 1rqqu - View Document | |
Microsoft Word - metalochlor update (2)DocID: 1rhIH - View Document | |
Microsoft Word - March 2012 Newsletter.docxDocID: 1r6Kj - View Document | |
^ & =» e: cr 03 (t 2 3 i-jas CD3 CL 3=11 o i ft)13 S3> 3- 3f CO p3.13DocID: 1r5tE - View Document | |
Microsoft Word - VO-103 Dry Cleaning Notes.docDocID: 1r0PQ - View Document |